Intuitive Surgical [ISRG] vs ResMed [RMD] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Intuitive Surgical, Inc. wins in 7 metrics, ResMed Inc. wins in 13 metrics, with 0 ties. ResMed Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Intuitive Surgical, Inc. ResMed Inc. Better
P/E Ratio (TTM) 54.97 21.69 ResMed Inc.
Price-to-Book Ratio 8.99 5.06 ResMed Inc.
Debt-to-Equity Ratio 0.95 13.41 Intuitive Surgical, Inc.
PEG Ratio 3.30 1.50 ResMed Inc.
EV/EBITDA 43.46 15.51 ResMed Inc.
Profit Margin (TTM) 28.38% 27.53% Intuitive Surgical, Inc.
Operating Margin (TTM) 30.16% 35.16% ResMed Inc.
EBITDA Margin (TTM) 30.16% 35.16% ResMed Inc.
Return on Equity 16.69% 25.68% ResMed Inc.
Return on Assets (TTM) 9.39% 14.75% ResMed Inc.
Free Cash Flow (TTM) $2.49B $1.65B Intuitive Surgical, Inc.
Dividend Yield N/A 0.92% N/A
1-Year Return -19.74% -21.88% Intuitive Surgical, Inc.
Price-to-Sales Ratio (TTM) 15.93 5.92 ResMed Inc.
Enterprise Value $154.62B $31.41B Intuitive Surgical, Inc.
EV/Revenue Ratio 15.36 5.82 ResMed Inc.
Gross Profit Margin (TTM) 66.44% 61.76% Intuitive Surgical, Inc.
Revenue per Share (TTM) $28 $37 ResMed Inc.
Earnings per Share (Diluted) $8.21 $10.12 ResMed Inc.
Beta (Stock Volatility) 1.68 0.93 ResMed Inc.
Short % of Float 1.91% 9.40% Intuitive Surgical, Inc.

Intuitive Surgical, Inc. vs ResMed Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Intuitive Surgical, Inc.1.34%-0.49%-1.09%-13.84%-25.55%-25.88%
ResMed Inc.-1.05%-0.21%-4.53%-16.42%-23.84%-21.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Intuitive Surgical, Inc.-19.74%24.81%40.32%476.52%974.11%3,431.44%
ResMed Inc.-21.88%-11.08%-17.97%233.76%527.92%775.81%

Performance & Financial Health Analysis: Intuitive Surgical, Inc. vs ResMed Inc.

MetricISRGRMD
Market Information
Market Cap i$170.06B$32.03B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,113,347955,842
90 Day Avg. Volume i1,799,7661,020,554
Last Close$416.55$192.74
52 Week Range$396.68 - $603.88$180.27 - $293.81
% from 52W High-31.02%-34.40%
All-Time High$616.00 (Jan 20, 2025)$301.34 (Sep 06, 2021)
% from All-Time High-32.38%-36.04%
Growth Metrics
Quarterly Revenue Growth0.19%0.11%
Quarterly Earnings Growth0.16%0.14%
Financial Health
Profit Margin (TTM) i0.28%0.28%
Operating Margin (TTM) i0.30%0.35%
Return on Equity (TTM) i0.17%0.26%
Debt to Equity (MRQ) i0.9513.41
Cash & Liquidity
Book Value per Share (MRQ)$50.19$43.39
Cash per Share (MRQ)$16.71$9.73
Operating Cash Flow (TTM) i$3.03B$1.91B
Levered Free Cash Flow (TTM) i$2.27B$1.42B
Dividends
Last 12-Month Dividend Yield iN/A0.92%
Last 12-Month Dividend iN/A$2.33

Valuation & Enterprise Metrics Analysis: Intuitive Surgical, Inc. vs ResMed Inc.

MetricISRG (Apr 24, 2026)RMD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i54.9721.69
Forward P/E i39.4918.02
PEG Ratio i3.301.50
Price to Sales (TTM) i15.935.92
Price to Book (MRQ) i8.995.06
Market Capitalization
Market Capitalization i$170.06B$32.03B
Enterprise Value i$154.62B$31.41B
Enterprise Value Metrics
Enterprise to Revenue i15.365.82
Enterprise to EBITDA i43.4615.51
Risk & Other Metrics
Beta i1.680.93
Book Value per Share (MRQ) i$50.19$43.39

Financial Statements Comparison: Intuitive Surgical, Inc. vs ResMed Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricISRG (2025)RMD (2025)
Revenue/Sales i10.06B5.15B
Cost of Goods Sold i3.42B2.09B
COGS % of Revenue i34.0%40.6%
Gross Profit i6.64B3.05B
Gross Margin i66.0%59.4%
Research & Development i1.31B331.28M
Operating Income (EBIT) i2.95B1.69B
Operating Margin i29.3%32.8%
EBITDA i3.62B1.93B
EBITDA Margin i36.0%37.4%
Pre-Tax Income i3.31B1.68B
Pre-Tax Income % of Revenue i32.9%32.6%
Income Tax i434.80M276.84M
Income Tax % of Revenue i4.3%5.4%
Net Income (Profit) i2.88B1.40B
Profit Margin i28.6%27.2%

Balance Sheet & Liquidity Metrics

MetricISRG (2025)RMD (2025)
Cash & Equivalents i3.37B1.21B
Total Current Assets i9.78B3.51B
Total Current Assets % of Revenue i97.2%68.1%
Total Current Liabilities i2.01B1.02B
Total Current Liabilities % of Revenue i19.9%19.8%
Long-Term Debt iN/A811.41M
Long-Term Debt % of Revenue i0.0%15.8%
Total Shareholders Equity i17.94B5.97B
Retained Earnings i7.01B6.08B
Retained Earnings % of Revenue i69.7%118.2%
Property, Plant & Equipment i2.10B288.62M

Cash Flow Statement Comparison

MetricISRG (2025)RMD (2025)
Operating Cash Flow i3.28B1.57B
Operating Cash Flow % of Revenue i32.5%30.5%
Capital Expenditures i-539.80M-89.87M
Free Cash Flow i2.49B1.65B
FCF Margin i24.7%32.1%
Debt Repayment iN/A-40.00M
Common Stock Repurchase i-2.30B-300.03M

Short Interest & Institutional Ownership Analysis

MetricISRGRMD
Shares Short i6.75M11.89M
Short Ratio i4.1911.24
Short % of Float i1.91%9.40%
Shares Outstanding i355.10M145.66M
Float Shares i352.94M144.79M
% Held by Insiders i0.56%0.50%
% Held by Institutions i89.20%68.82%
% Held by Public i10.24%30.68%

Dividend Analysis & Yield Comparison: Intuitive Surgical, Inc. vs ResMed Inc.

MetricISRGRMD
Last 12-Month Dividend iN/A$2.33
Last 12-Month Dividend Yield iN/A0.92%
3-Year Avg Annual Dividend iN/A$2.09
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$6.28
Ex-Dividend DateN/AFeb 12, 2026